Switzerland · Series A startup

Who invested in Rhygaze

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$86Mraised across 1 round since 2025, from 1 source

Latest round
Series A, $86MJan 2025
Investors
3
See who backed them

The rounds

  1. Jan 2025

Founders and team

From Rhygaze's own website: 8 on the team.

  • Katherine HighChief Executive Officer
  • Dan TakefmanChief Development Officer
  • Heather FloydChief Operating Officer
  • Linda CoutoChief Scientific Officer
  • Paulo FalabellaChief Medical Officer
  • Bence GyörgyIOB Assistant Professor & Head of Clinical Translation
  • Botond RoskaIOB Co-Director
  • Tracy DowlingTeam

Everyone who backed them

Google VenturesCorporate VC1round
NovartisVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Rhygaze

Who invested in Rhygaze?

Rhygaze's investors include Google Ventures, ARCH Venture Partners and Novartis.

How much has Rhygaze raised?

Rhygaze has raised $86M across 1 round since 2025.

When did Rhygaze last raise?

Rhygaze's most recent round was a Series A of $86M in Jan 2025.

What was Rhygaze's biggest round?

Its most recent round, $86M in Jan 2025, is also its largest on record.

Who backed Rhygaze first?

Rhygaze's first round on record, in Jan 2025, was backed by Google Ventures, ARCH Venture Partners and Novartis.

What stage is Rhygaze at?

Rhygaze's latest named round is a Series A, in Jan 2025.

Where is Rhygaze based?

Rhygaze is based in Switzerland.

Companies like Rhygaze

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.